• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Stem Cells

Frequency Therapeutics registers $100m IPO

September 9, 2019 By Sean Whooley

Frequency Therapeutics updated logo

Frequency Therapeutics has registered an initial public offering of common stock worth $100 million. Woburn, Mass.-based Frequency Therapeutics did not disclose the number of shares it seeks to sell or the price range of the offered units. The company applied to the Securities and Exchange Commission have its common stock listed on The Nasdaq Global […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Hydrogels, Initial Public Offering (IPO), Otolaryngology Ear, Nose & Throat, Research & Development, Stem Cells Tagged With: Frequency Therapeutics

AxoSim touts results of nerve-on-a-chip study

July 9, 2019 By Nancy Crotti

AxoSim

A new study of AxoSim’s Nerve-on-a-Chip technology shows that the platform accurately provides key physiological readouts that could help speed the development of drugs to treat neurological disorders. The study also shows that Nerve-on-a-Chip technology is the first all-human in vitro model that can measure critical factors that were formerly only available using live animal models. […]

Filed Under: Featured, Neurological, Research & Development, Stem Cells Tagged With: AxoSim

Anika collabs to develop injectable stem cell therapy for osteoarthritis

February 2, 2018 By Sarah Faulkner

Anika Therapeutics

Anika Therapeutics (NSDQ:ANIK) has inked an agreement with the Institute of Integrative Biology at the University of Liverpool to develop an injectable mesenchymal stem cell therapy to treat osteoarthritis. As a result of the three-year research collaboration, the group hopes to have a lead candidate that it can take into clinical trials. “We are very excited […]

Filed Under: Drug-Device Combinations, Featured, Orthopedics, Pharmaceuticals, Stem Cells, Wall Street Beat Tagged With: Anika Therapeutics Inc., University of Liverpool

Semma Therapeutics closes $114m round to advance cell therapy for Type I diabetes

November 30, 2017 By Sarah Faulkner

Semma Therapeutics

Semma Therapeutics has closed an oversubscribed $114 million Series B round to help fund the development of its encapsulated stem cell-derived islet therapy for Type I diabetes. The Cambridge, Mass.-based company reported that it plans to use the newly-acquired funds to bring its cell therapy through clinical proof-of-concept studies, as well as explore other regenerative […]

Filed Under: Diabetes, Featured, Funding Roundup, Stem Cells Tagged With: Juvenile Diabetes Research Foundation (JDRF), Medtronic, Novartis, Semma Therapeutics

Researchers reverse diabetes in mice by infusing them with blood stem cells

November 17, 2017 By Sarah Faulkner

diabetes cell therapy

Researchers at Boston Children’s Hospital successfully reversed Type I diabetes in a mouse model using blood stem cells, according to a study published this week in Science Translational Medicine. The researchers used cells that were pre-treated to make more of a protein, PD-L1, which is deficient in mice and people with Type I diabetes. “There’s really […]

Filed Under: Diabetes, Featured, Pharmaceuticals, Regenerative Medicine, Research & Development, Stem Cells Tagged With: Boston Children's Hospital

BrainStorm enrolls first ALS patient in late-stage NurOwn trial

October 16, 2017 By Sarah Faulkner

BrainStorm Cell Therapeutics

Brainstorm Cell Therapeutics (NSDQ:BCLI) said today that the first patients have been enrolled in its Phase III trial evaluating NurOwn as a treatment for amyotrophic lateral sclerosis, or ALS, at Massachusetts General Hospital and UC Irvine Medical Center. The trial, which is slated to enroll 200 patients, is designed to include the pre-specified patient subgroups who […]

Filed Under: Clinical Trials, Featured, Neurological, Stem Cells, Wall Street Beat Tagged With: Brainstorm Cell Therapeutics

FDA intervenes after stem cell center offers unproven treatment to cancer patients

August 28, 2017 By Sarah Faulkner

FDA

The FDA is cracking down on stem cell clinics that administer unproven and potentially dangerous treatments to patients, citing a California-based clinic that the regulatory watchdog said was treating cancer patients with the smallpox vaccine. Last week, the U.S. Marshals Service seized five vials of a vaccine that is reserved only for people at high […]

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Stem Cells

Gamida Cell launches severe aplastic anemia trial

August 21, 2017 By Sarah Faulkner

Gamida Cell

Gamida Cell said today that the first patient has been transplanted in a study of its CordIn product for patients with severe aplastic anemia or hypoplastic myelodysplastic syndrome. The product is designed for patients with rare genetic diseases who have no fully-matched donors for a bone marrow transplantation. Gamida Cell said it is also evaluating […]

Filed Under: Clinical Trials, Featured, Stem Cells Tagged With: Gamida Cell

Anika Therapeutics touts Hyalofast scaffold, stem cell combo

August 8, 2017 By Sarah Faulkner

Anika Therapeutics

Anika Therapeutics (NSDQ:ANIK) touted data today from a study evaluating the use of its Hyalofast biodegradable, hyaluronic acid-based scaffold in combination with autologous adult mesenchymal stem cells as a treatment for cartilage lesions in the knee. The study, which was published in Knee Surgery Sports Traumatology Arthroscopy, showed that the treatment was equally effective among patients, regardless […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Pharmaceuticals, Stem Cells, Wall Street Beat Tagged With: Anika Therapeutics Inc.

Researchers develop stem cell therapy to fight inflammatory lung conditions

August 4, 2017 By Sarah Faulkner

Researchers from the UNC School of Medicine and North Carolina State University showed that they could harvest and multiply lung stem cells in volumes sufficient for human therapy.  In a second study, the team used their cell therapy to treat a model of idiopathic pulmonary fibrosis. The scientists reported that they are in talks with […]

Filed Under: Featured, Pharmaceuticals, Regenerative Medicine, Research & Development, Stem Cells

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 6
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS